NCT05891262View on ClinicalTrials.gov

A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

August 25, 2023

Study Completion Date

August 25, 2023

Conditions
Healthy Female Volunteers
Interventions
DRUG

BMS-986196

Specified dose on specified days

DRUG

Loestrin

Specified dose on specified days

Trial Locations (1)

90630

Altasciences, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05891262 - A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants | Biotech Hunter | Biotech Hunter